147 related articles for article (PubMed ID: 37858127)
1. Assessment of MYC and TERT copy number variations in lung cancer using digital PCR.
Brik A; Wichert K; Weber DG; Szafranski K; Rozynek P; Meier S; Ko YD; Büttner R; Gerwert K; Behrens T; Brüning T; Johnen G
BMC Res Notes; 2023 Oct; 16(1):279. PubMed ID: 37858127
[TBL] [Abstract][Full Text] [Related]
2. Digital PCR for the Analysis of
Brik A; Weber DG; Casjens S; Rozynek P; Meier S; Behrens T; Stamatis G; Darwiche K; Theegarten D; Brüning T; Johnen G
Dis Markers; 2020; 2020():4176376. PubMed ID: 33014186
[TBL] [Abstract][Full Text] [Related]
3. Concordant expression of the telomerase-associated genes in non-small cell lung cancer.
Hsu CP; Miaw J; Hsia JY; Shai SE; Chen CY
Eur J Surg Oncol; 2003 Sep; 29(7):594-9. PubMed ID: 12943625
[TBL] [Abstract][Full Text] [Related]
4. The correlation of TERT expression with c-myc expression in cervical cancer.
Sagawa Y; Nishi H; Isaka K; Fujito A; Takayama M
Cancer Lett; 2001 Jul; 168(1):45-50. PubMed ID: 11368876
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
McKelvey BA; Zeiger MA; Umbricht CB
Genes Chromosomes Cancer; 2021 Jun; 60(6):403-409. PubMed ID: 33305870
[TBL] [Abstract][Full Text] [Related]
6. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Geng Z; Zhang D; Liu Y
Chin Med J (Engl); 2003 Oct; 116(10):1467-70. PubMed ID: 14570602
[TBL] [Abstract][Full Text] [Related]
7. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
8. Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction.
Mitani S; Kamata H; Fujiwara M; Aoki N; Tango T; Fukuchi K; Oka T
Clin Exp Med; 2001 Jun; 1(2):105-11. PubMed ID: 11699727
[TBL] [Abstract][Full Text] [Related]
9. Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
Mavrogiannou E; Strati A; Stathopoulou A; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Jan; 53(1):53-61. PubMed ID: 17130181
[TBL] [Abstract][Full Text] [Related]
10. The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma.
Yu J; Yu J; Wu X; Guo Q; Yin T; Cheng Z; Dai J; Kong Y; Guo J
Clin Sci (Lond); 2020 Jan; 134(2):193-205. PubMed ID: 31919521
[TBL] [Abstract][Full Text] [Related]
11. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
12. Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation.
Whale AS; Huggett JF; Cowen S; Speirs V; Shaw J; Ellison S; Foy CA; Scott DJ
Nucleic Acids Res; 2012 Jun; 40(11):e82. PubMed ID: 22373922
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
14. Establishment and evaluation of digital PCR methods for HER2 copy number variation in breast cancer.
Wang X; Xing D; Liu Z; Zhang Y; Cheng B; Sun S; Wang Q; Dong L
Anal Bioanal Chem; 2023 Feb; 415(4):725-733. PubMed ID: 36571590
[TBL] [Abstract][Full Text] [Related]
15. Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients.
Lee KS; Nam SK; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
Sci Rep; 2019 Feb; 9(1):1611. PubMed ID: 30733532
[TBL] [Abstract][Full Text] [Related]
16. Identification of metabolic signatures associated with erlotinib resistance of non-small cell lung cancer cells.
Serizawa M; Kusuhara M; Zangiacomi V; Urakami K; Watanabe M; Takahashi T; Yamaguchi K; Yamamoto N; Koh Y
Anticancer Res; 2014 Jun; 34(6):2779-87. PubMed ID: 24922639
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
Seo AN; Yang JM; Kim H; Jheon S; Kim K; Lee CT; Jin Y; Yun S; Chung JH; Paik JH
Br J Cancer; 2014 May; 110(11):2688-99. PubMed ID: 24809777
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung.
Alidousty C; Duerbaum N; Wagener-Ryczek S; Baar T; Martelotto LG; Heydt C; Siemanowski J; Holz B; Binot E; Fassunke J; Merkelbach-Bruse S; Wolf J; Kron A; Buettner R; Schultheis AM
Histopathology; 2021 Mar; 78(4):578-585. PubMed ID: 32946634
[TBL] [Abstract][Full Text] [Related]
19. MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.
Flacco A; Ludovini V; Bianconi F; Ragusa M; Bellezza G; Tofanetti FR; Pistola L; Siggillino A; Vannucci J; Cagini L; Sidoni A; Puma F; Varella-Garcia M; Crinò L
Am J Clin Oncol; 2015 Apr; 38(2):152-8. PubMed ID: 25806711
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.
Almodovar K; Iams WT; Meador CB; Zhao Z; York S; Horn L; Yan Y; Hernandez J; Chen H; Shyr Y; Lim LP; Raymond CK; Lovly CM
J Thorac Oncol; 2018 Jan; 13(1):112-123. PubMed ID: 28951314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
